AAAAAA

   
Results: 1-12 |
Results: 12
PACLITAXEL IN ANTHRACYCLINE-TREATED BREAST-CANCER PATIENTS
Authors: PUGLIESE P BRUGNATELLI S GIORDANO M DANOVA M DEMONTE A RICHETTI A FAVA S RINALDI E FREGONI V EPIFANI C RICCARDI A
Citation: P. Pugliese et al., PACLITAXEL IN ANTHRACYCLINE-TREATED BREAST-CANCER PATIENTS, Oncology Reports, 5(4), 1998, pp. 915-918
CD11B EXPRESSION ON LYMPHOCYTES (LY) OF RENAL-CELL CARCINOMA (RCC) PATIENTS AFTER A SINGLE COURSE OF VERY LOW-DOSE SC IL-2
Authors: PORTA C MAZZUCCHELLI I FERRARI S MORONI M FOSSATI GL RICCI G DANOVA M BRUGNATELLI S RICCARDI A
Citation: C. Porta et al., CD11B EXPRESSION ON LYMPHOCYTES (LY) OF RENAL-CELL CARCINOMA (RCC) PATIENTS AFTER A SINGLE COURSE OF VERY LOW-DOSE SC IL-2, Annals of oncology, 9, 1998, pp. 294-294
RELEVANCE OF AGE ON SURVIVAL OF 341 PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH CONVENTIONAL CHEMOTHERAPY - UPDATED RESULTS OF THE MM87 PROSPECTIVE RANDOMIZED PROTOCOL
Authors: RICCARDI A MORA O BRUGNATELLI S TINELLI C SPANEDDA R DEPAOLI A BARBARANO L DISTASI M BERGONZI C GIORDANO M DELFINI C NICOLETTI G RINALDI E PICCININI L VALENTINI D ASCARI E
Citation: A. Riccardi et al., RELEVANCE OF AGE ON SURVIVAL OF 341 PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH CONVENTIONAL CHEMOTHERAPY - UPDATED RESULTS OF THE MM87 PROSPECTIVE RANDOMIZED PROTOCOL, British Journal of Cancer, 77(3), 1998, pp. 485-491
TOXICITY DATA OF A MULTICENTER, RANDOMIZED STUDY OF STANDARD FEC (FEC60) VS FEC WITH DOUBLE EPIRUBICIN (EPI) (FEC120) PLUS G-CSF IN METASTATIC BREAST-CANCER (MBC)
Authors: RICCARDI A BRUGNATELLI S GIORDANO M DANOVA M TINELLI C
Citation: A. Riccardi et al., TOXICITY DATA OF A MULTICENTER, RANDOMIZED STUDY OF STANDARD FEC (FEC60) VS FEC WITH DOUBLE EPIRUBICIN (EPI) (FEC120) PLUS G-CSF IN METASTATIC BREAST-CANCER (MBC), European journal of cancer, 33, 1997, pp. 697-697
ORAL IDARUBICIN AND PREDNISONE FOR ADVANCED, PREVIOUSLY UNTREATED, MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: BRUGNATELLI S RICCARDI A UCCI G PETRINI M GIORDANO M BARBARANO L BERGONZI C DEPAOLI A CAVANNA L ASCARI E
Citation: S. Brugnatelli et al., ORAL IDARUBICIN AND PREDNISONE FOR ADVANCED, PREVIOUSLY UNTREATED, MULTIPLE-MYELOMA - A PILOT-STUDY, Annals of oncology, 7(5), 1996, pp. 537-538
A PROGNOSTIC INDEX FOR MULTIPLE-MYELOMA
Authors: GRIGNANI G GOBBI PG FORMISANO R PIERESCA C UCCI G BRUGNATELLI S RICCARDI A ASCARI E
Citation: G. Grignani et al., A PROGNOSTIC INDEX FOR MULTIPLE-MYELOMA, British Journal of Cancer, 73(9), 1996, pp. 1101-1107
EXPERIENCE WITH POORLY MYELOSUPPRESSIVE CHEMOTHERAPY SCHEDULES FOR ADVANCED MYELOMA
Authors: BRUGNATELLI S RICCARDI A UCCI G MORA O BARBARANO L PIVA N PICCININI L BERGONZI C DEPAOLI A DISTASI M RINALDI E TROTTI G PETRINI M ASCARI E
Citation: S. Brugnatelli et al., EXPERIENCE WITH POORLY MYELOSUPPRESSIVE CHEMOTHERAPY SCHEDULES FOR ADVANCED MYELOMA, British Journal of Cancer, 73(6), 1996, pp. 794-797
ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL
Authors: RICCARDI A GIORDANO M BRUGNATELLI S UCCI G DANOVA M MORA O FAVA S ASCARI E
Citation: A. Riccardi et al., ADVANCED BREAST-CANCER - A RANDOMIZED STUDY OF DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL, Oncology Reports, 2(4), 1995, pp. 577-582
DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL - A RANDOMIZED STUDY IN ADVANCED BREAST-CANCER
Authors: RICCARDI A GIORDANO M BRUGNATELLI S UCCI G DANOVA M MORA O FAVA S ASCARI E
Citation: A. Riccardi et al., DIFFERENT DOSES OF EPIRUBICIN ASSOCIATED WITH FIXED DOSES OF CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL - A RANDOMIZED STUDY IN ADVANCED BREAST-CANCER, European journal of cancer, 31A(9), 1995, pp. 1549-1551
A SHORT-TERM INFUSION REGIMEN OF CISPLATIN, 5-FLUOROURACIL AND L-FOLINIC ACID IN ADVANCED HEAD AND NECK-CARCINOMA
Authors: MELI M PALMERI S LEONARDI V DANOVA M FAILLA G RUSSO A BRUGNATELLI S FERRARA P BENAZZO M RAUSA L
Citation: M. Meli et al., A SHORT-TERM INFUSION REGIMEN OF CISPLATIN, 5-FLUOROURACIL AND L-FOLINIC ACID IN ADVANCED HEAD AND NECK-CARCINOMA, Oncology Reports, 1(6), 1994, pp. 1133-1138
A PROSPECTIVE, CONTROLLED, NONRANDOMIZED STUDY ON PROPHYLACTIC PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN MULTIPLE-MYELOMA
Authors: RICCARDI A UCCI G BRUGNATELLI S MORA O MERLINI G PIVA N DEPAOLI A BARBARANO L DISTASI M ALBERIO F NICOLETTI G MORANDI S RINALDI E PICCININI L ASCARI E
Citation: A. Riccardi et al., A PROSPECTIVE, CONTROLLED, NONRANDOMIZED STUDY ON PROPHYLACTIC PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN MULTIPLE-MYELOMA, International journal of oncology, 5(4), 1994, pp. 833-839
TREATMENT OF MULTIPLE-MYELOMA ACCORDING TO THE EXTENSION OF THE DISEASE - A PROSPECTIVE, RANDOMIZED STUDY COMPARING A LESS WITH A MORE AGGRESSIVE CYTOSTATIC POLICY
Authors: RICCARDI A UCCI G LUONI R BRUGNATELLI S MORA O SPANEDDA R DEPAOLI A BARBARANO L DISTASI M ALBERIO F DELFINI C NICOLETTI G MORANDI S RINALDI E PICCININI L DEPASQUALE A ASCARI E
Citation: A. Riccardi et al., TREATMENT OF MULTIPLE-MYELOMA ACCORDING TO THE EXTENSION OF THE DISEASE - A PROSPECTIVE, RANDOMIZED STUDY COMPARING A LESS WITH A MORE AGGRESSIVE CYTOSTATIC POLICY, British Journal of Cancer, 70(6), 1994, pp. 1203-1210
Risultati: 1-12 |